Maize CAB Promoter for Tissue-Specific Transgene Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current plant transformation technologies face challenges in achieving high expression of multiple transgenes stacked at a single genomic locus and in targeting specific tissue expression of transgenes in plants, leading to inefficiencies in trait development and potential gene silencing.

Innovation Solution

The use of Zea mays chlorophyll a/b binding gene promoter regulatory elements in gene expression cassettes, which include specific promoters, introns, and untranslated regions, to drive the expression of transgenes in plant cells and tissues, allowing for tissue-preferred and efficient expression of desirable traits such as insecticidal resistance, herbicide tolerance, and nutritional quality.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Power

If multiple transgenes are stacked at a single genomic locus to achieve high expression, then transgene expression level is improved, but gene silencing occurs

Engineering Contradiction:
Improvetransgene expression levelVSAvoidgene silencing
Core Design Contradiction:
PowerVSReliability

Solution Approach 1:

The patent applies tissue-specific promoters (e.g., leaf-specific, root-specific, stem-specific) to control transgene expression in particular plant tissues. This localizes the expression to avoid systemic gene silencing while maintaining high expression levels in the target tissue, thereby resolving the contradiction between high expression and gene silencing.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent divides the transgene expression system into separate tissue-specific modules, each with its own promoter and regulatory elements. This segmentation allows independent control of expression in different tissues, preventing the silencing that would occur with constitutive high-level expression throughout the entire plant.

Inventive Principle:
Principle #1Segmentation

2Adaptability or versatility

If transgenes are expressed in specific tissues to achieve targeted resistance or function, then functional specificity is improved, but expression efficiency decreases

Engineering Contradiction:
Improvetissue-specific expressionVSAvoidexpression efficiency
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The patent employs tissue-specific promoters that are naturally active in specific plant tissues (leaf, root, stem, flower) to achieve targeted transgene expression. This local quality approach ensures high expression efficiency within the target tissue while avoiding unnecessary expression in other tissues, thus maintaining both specificity and efficiency.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent uses tissue-specific transcription factors and regulatory elements as intermediaries to control transgene expression. These intermediaries activate the transgene only in the presence of specific tissue conditions, ensuring efficient and targeted expression without requiring constitutive high-level expression throughout the plant.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Device complexity

If conventional promoters are used to drive transgene expression, then simplicity of construction is maintained, but expression control and specificity are reduced

Engineering Contradiction:
Improvepromoter construct simplicityVSAvoidexpression control
Core Design Contradiction:
Device complexityVSAdaptability or versatility

Solution Approach 1:

The patent utilizes naturally occurring tissue-specific promoters from maize that are already optimized for their specific tissues. These promoters provide built-in expression control without requiring complex artificial construct design, maintaining simplicity while achieving precise tissue-specific expression control through the inherent properties of the promoters.

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS9650641B2<i>Zea mays </i>promoter from chlorophyll a/b binding protein gene and uses thereof
Publication Date: 2017.05.16 CORTEVA AGRISCIENCE LLC
  • US9650641B2 patent drawing
  • US9650641B2 patent drawing
  • US9650641B2 patent drawing

AI summary

Provided are constructs and methods for expressing a transgene in plant cells and/or plant tissues using Zea mays chlorophyll a/b binding gene regulatory elements.